Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xenetic Biosciences Inc (NQ: XBIO ) 4.170 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 4.170 Bid (Size) 1.670 (2) Ask (Size) 6.000 (1) Prev. Close 4.170 Today's Range 4.170 - 4.170 52wk Range 2.870 - 5.970 Shares Outstanding 1,540,684 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Xenetic Biosciences, Inc. Announces Executive Leadership Transition May 22, 2024 Via ACCESSWIRE Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update May 10, 2024 Via ACCESSWIRE Performance YTD +16.97% +16.97% 1 Month -0.71% -0.71% 3 Month +10.44% +10.44% 6 Month +27.52% +27.52% 1 Year -0.00% -0.00% More News Read More XBIO Stock Earnings: Xenetic Biosciences Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace XBIO Stock Earnings: Xenetic Biosciences Beats EPS, Misses Revenue for Q4 2023 March 22, 2024 Via InvestorPlace Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results March 22, 2024 Via ACCESSWIRE Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform January 17, 2024 Via ACCESSWIRE Xenetic Biosciences: Q3 Earnings Insights November 10, 2023 Via Benzinga Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference October 11, 2023 Via ACCESSWIRE Xenetic Biosciences, Inc. Reports Second Quarter 2023 Financial Results August 11, 2023 Via ACCESSWIRE Xenetic Biosciences, Inc. to Participate in the Virtual Investor Summer Spotlight Series July 05, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Tuesday's Intraday Session December 05, 2023 Via Benzinga Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results November 10, 2023 Via ACCESSWIRE Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 05, 2023 Via ACCESSWIRE 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 20, 2023 Via Benzinga Lack Of Catalysts Prompts Analyst To Downgrade Xenetic Biosciences May 16, 2023 Via Benzinga Xenetic Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update May 11, 2023 Via ACCESSWIRE Xenetic Biosciences, Inc. Adds Business Development Expertise with Appointment of Scott N. Cullison May 03, 2023 Via ACCESSWIRE Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 15, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 12, 2023 Via Benzinga Xenetic Biosciences, Inc. Announces Reverse Stock Split of Common Stock May 12, 2023 Via ACCESSWIRE Xenetic Biosciences, Inc. Bolsters R&D and Regulatory Expertise with Appointment of Reid P. Bissonnette, Ph.D. as Executive Consultant for Translational Research and Development May 04, 2023 Via ACCESSWIRE Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention April 13, 2023 Via Benzinga Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules April 13, 2023 Via Benzinga New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications April 12, 2023 Via Benzinga Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead April 11, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
